March 18, 2024 – Talk Bio

AstraZeneca and GSK Join Boehringer Ingelheim in Capping Out-of-Pocket Inhaler Costs at $35 per Month

1 year ago talkbio0Tagged accessibility, AstraZeneca, GlaxoSmithKline/ Boehringer, Ingelheim, out-of-pocket costs/ cap/, Prices, U.S./ congressional

AstraZeneca/ GlaxoSmithKline/ Boehringer Ingelheim/ inhaler/ out-of-pocket costs/ cap/ $35/ asthma/ COPD/ price reduction/ drug pricing/ U.S./ congressional scrutiny/ patient affordability/ medication accessibility.

Pfizer Reduces Stake in Haleon, Raising Over $2 Billion in Share Selloff

1 year ago talkbio0Tagged Consumer Health Spinoff, Debt Management, Haleon, Pfizer, Stake Reduction, Strategic Focus

Pfizer, Haleon, Consumer Health Spinoff, Share Selloff, Stake Reduction, GSK, Debt Management, Strategic Focus

Contineum Launches IPO Campaign to Accelerate Multiple Sclerosis Pipeline

1 year ago talkbio0Tagged Backed, Contineum, IPO, Johnson and Johnson, Multiple Sclerosis, Phase 2 Clinical Trials, PIPE-307, Public Offering

Contineum Therapeutics, Initial Public Offering (IPO), Johnson & Johnson (J&J) Backed, Multiple Sclerosis (MS) Pipeline, Phase II Trial, PIPE-307